Results 241 to 250 of about 23,557,656 (289)

Hijacking emergency granulopoiesis: Neutrophil ontogeny and reprogramming in cancer

open access: yesMolecular Oncology, EarlyView.
Neutrophils are highly plastic innate immune cells; their functions in cancer extend beyond the tumour microenvironment. This Review summarises current understanding of neutrophil maturation and heterogeneity and highlights tumour‐induced granulopoiesis as a systemic programme that expands immature, immunosuppressive neutrophils via tumour‐derived ...
Gabriela Marinescu, Yi Feng
wiley   +1 more source

Transcriptional profiling of circulating extracellular vesicles from prebiopsy prostate cancer patients

open access: yesMolecular Oncology, EarlyView.
RNA profiling of circulating extracellular vesicles (EVs) from blood samples of men undergoing prostate biopsy identifies transcripts associated with clinically significant prostate cancer. Integrative analysis with public tumor datasets links EV‐derived gene signatures to tumor stage and progression‐free survival, highlighting CASP3, XRCC2, and RIT1 ...
Stefan Werner   +14 more
wiley   +1 more source

Metastasis on pause: How dormant tumor cells stay hidden within the tumor microenvironment and evade immune surveillance

open access: yesMolecular Oncology, EarlyView.
Dormant cancer cells can hide in distant organs for years, evading treatment and the immune system. This review highlights how signals from the surrounding tissue and immune environment keep these cells inactive or trigger their reawakening. Understanding these mechanisms may help develop therapies to eliminate or control dormant cells and prevent ...
Kanishka Tiwary   +1 more
wiley   +1 more source

Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma

open access: yesMolecular Oncology, EarlyView.
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska   +13 more
wiley   +1 more source

Swedish Consensus Recommendation for Follow-Up After ICU Stay. [PDF]

open access: yesActa Anaesthesiol Scand
Åkerman E   +4 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Longitudinal follow‐up studies

Acta Paediatrica, 1994
A longitudinal study should be undertaken only when there is a clear reason to justify this and a reasonable chance of achieving the objectives. A multidisciplinary approach is often required, and continuity of staff and long‐term collaboration with colleagues are important for their success.
C, Peckham, M L, Newell
openaire   +2 more sources

Sigmoidocystoplasty: a Follow-Up Study

European Urology, 1980
Sigmoidocystoplasty was performed in 62 patients. 36 were followed up. The mean observation period was 68 months, ranging from 6 to 318 months. In 18 patients the results were considered as good, 11 were improved after the operation and in 6 cases the situation was unchanged.
B, Kvarstein, W, Mathisen, E, Steinsvik
openaire   +2 more sources

Follow up study

Nursing Standard, 1989
I would like to contact all Registered Nurses who undertook a shortened course for graduates at the Queen Elizabeth School of Nursing, Birmingham. This is to enable me to evaluate the course and conduct a follow up study of career pathways after qualification.
openaire   +2 more sources

Depression and cancer: a follow-up study

Psychological Medicine, 1979
SYNOPSISThirty-nine male and 90 female patients aged 40 and over, who had been given a primary diagnosis of depression, were followed up for 2⅓;13–4 years. During this period 9 male and 9 female patients died. Five male patients and 1 female died from cancer that had not been diagnosed at the time of their psychiatric admissions. The male cancer deaths
Whitlock F.A., Siskind M.
openaire   +4 more sources

Home - About - Disclaimer - Privacy